Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABGLF OTCMKTS:CLIGF OTCMKTS:FXCNY OTCMKTS:HCHDF OTCMKTS:ZLDPF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABGLFAcacia Mining$3.09$3.09$1.99▼$3.09$1.27BN/A32,275 shsN/ACLIGFClinigen Group$8.02$8.02$8.02▼$11.56$1.07B0.498,620 shsN/AFXCNYFIH Mobile$19.50$16.54$1.50▼$2.67$7.68BN/A968 shsN/AHCHDFHochschild Mining$4.13-4.2%$4.02$2.11▼$4.73$2.22B0.5441,097 shs32,953 shsZLDPFZealand Pharma A/S$73.31+6.2%$60.98$49.98▼$135.65$4.90B0.73156 shs130 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABGLFAcacia Mining0.00%0.00%0.00%0.00%0.00%CLIGFClinigen Group0.00%0.00%0.00%0.00%0.00%FXCNYFIH Mobile0.00%-2.48%+0.91%+65.21%+938.35%HCHDFHochschild Mining-4.02%-8.43%+5.90%+26.69%+86.88%ZLDPFZealand Pharma A/S+6.25%+6.22%+20.18%+23.94%-45.05%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABGLFAcacia Mining$3.09$3.09$1.99▼$3.09$1.27BN/A32,275 shsN/ACLIGFClinigen Group$8.02$8.02$8.02▼$11.56$1.07B0.498,620 shsN/AFXCNYFIH Mobile$19.50$16.54$1.50▼$2.67$7.68BN/A968 shsN/AHCHDFHochschild Mining$4.13-4.2%$4.02$2.11▼$4.73$2.22B0.5441,097 shs32,953 shsZLDPFZealand Pharma A/S$73.31+6.2%$60.98$49.98▼$135.65$4.90B0.73156 shs130 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABGLFAcacia Mining0.00%0.00%0.00%0.00%0.00%CLIGFClinigen Group0.00%0.00%0.00%0.00%0.00%FXCNYFIH Mobile0.00%-2.48%+0.91%+65.21%+938.35%HCHDFHochschild Mining-4.02%-8.43%+5.90%+26.69%+86.88%ZLDPFZealand Pharma A/S+6.25%+6.22%+20.18%+23.94%-45.05%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABGLFAcacia Mining 0.00N/AN/AN/ACLIGFClinigen Group 0.00N/AN/AN/AFXCNYFIH Mobile 0.00N/AN/AN/AHCHDFHochschild Mining 3.25BuyN/AN/AZLDPFZealand Pharma A/S 3.57Strong BuyN/AN/ACurrent Analyst Ratings BreakdownLatest CLIGF, ZLDPF, HCHDF, ABGLF, and FXCNY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/15/2025ZLDPFZealand Pharma A/SZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/15/2025ZLDPFZealand Pharma A/SZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell7/24/2025ZLDPFZealand Pharma A/SWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy7/7/2025ZLDPFZealand Pharma A/SBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy7/1/2025ZLDPFZealand Pharma A/SBNP ParibasSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy(Data available from 9/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABGLFAcacia MiningN/AN/AN/AN/AN/AN/ACLIGFClinigen Group$704.71M1.51$1.43 per share5.60$4.52 per share1.77FXCNYFIH Mobile$6.45B1.19$0.62 per share31.43$3.96 per share4.92HCHDFHochschild Mining$947.70M2.24$0.52 per share8.00$1.34 per share3.08ZLDPFZealand Pharma A/S$9.09M572.77N/AN/A$17.59 per share4.17Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABGLFAcacia MiningN/AN/A0.00∞N/AN/AN/AN/AN/ACLIGFClinigen Group$40.78MN/A0.00∞N/AN/AN/AN/AN/AFXCNYFIH Mobile-$120.68MN/A0.00∞N/AN/AN/AN/AN/AHCHDFHochschild Mining$97MN/A0.00∞N/AN/AN/AN/AN/AZLDPFZealand Pharma A/S-$156.43M$14.245.15N/AN/A73.90%67.06%61.12%11/6/2025 (Estimated)Latest CLIGF, ZLDPF, HCHDF, ABGLF, and FXCNY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025ZLDPFZealand Pharma A/S$16.72$16.06-$0.66$16.06$9.18 billion$1.43 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABGLFAcacia MiningN/AN/AN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AN/AN/AFXCNYFIH Mobile$0.060.32%N/AN/AN/AHCHDFHochschild Mining$0.020.48%N/AN/AN/AZLDPFZealand Pharma A/SN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABGLFAcacia MiningN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AFXCNYFIH MobileN/A1.220.83HCHDFHochschild Mining0.260.750.53ZLDPFZealand Pharma A/S0.0215.0915.08Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABGLFAcacia MiningN/ACLIGFClinigen GroupN/AFXCNYFIH MobileN/AHCHDFHochschild MiningN/AZLDPFZealand Pharma A/SN/AInsider OwnershipCompanyInsider OwnershipABGLFAcacia MiningN/ACLIGFClinigen GroupN/AFXCNYFIH MobileN/AHCHDFHochschild MiningN/AZLDPFZealand Pharma A/SN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABGLFAcacia Mining1,331410.09 millionN/ANot OptionableCLIGFClinigen Group1,069133.03 millionN/ANot OptionableFXCNYFIH Mobile6,657394.12 millionN/ANot OptionableHCHDFHochschild Mining3,309514.46 millionN/ANot OptionableZLDPFZealand Pharma A/S34071.02 millionN/ANot OptionableCLIGF, ZLDPF, HCHDF, ABGLF, and FXCNY HeadlinesRecent News About These CompaniesZealand Pharma A/S (OTCMKTS:ZLDPF) Receives Consensus Recommendation of "Strong Buy" from Analysts4 hours ago | americanbankingnews.comEuropean stocks rise as monetary policy holds spotlight; Zealand Pharma gains 7%September 18 at 10:33 AM | msn.comZealand Pharma A/S (OTCMKTS:ZLDPF) Upgraded by Zacks Research to "Hold" RatingSeptember 18 at 6:55 AM | marketbeat.comZacks Research Upgrades Zealand Pharma A/S (OTCMKTS:ZLDPF) to HoldSeptember 18 at 2:11 AM | americanbankingnews.comZealand Pharma A/S (OTCMKTS:ZLDPF) Given Consensus Recommendation of "Buy" by BrokeragesSeptember 16 at 4:39 AM | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Down - Here's WhySeptember 12, 2025 | marketbeat.comICON Plc and Zealand Pharma’s Petrelintide Study: A Key Update for InvestorsSeptember 7, 2025 | msn.comZealand Pharma A/S (OTCMKTS:ZLDPF) Shares Gap Up - Still a Buy?September 5, 2025 | marketbeat.comDeutsche Bank Remains a Hold on Zealand Pharma (ZLDPF)August 25, 2025 | theglobeandmail.comZealand Pharma A/S (OTCMKTS:ZLDPF) Sees Large Drop in Short InterestAugust 22, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Given Consensus Rating of "Buy" by AnalystsAugust 21, 2025 | marketbeat.comWilliam Blair Estimates OTCMKTS:ZLDPF Q3 EarningsAugust 19, 2025 | marketbeat.comZealand Pharma A/S (ZLDPF) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comZealand CEO: Oral weight loss meds are not the future for treating obesityMay 15, 2025 | seekingalpha.comZealand Pharma A/S (ZLDPF) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comZealand Pharma AS (ZLDPF) Q1 2025 Earnings Call Highlights: Strategic Collaborations and ...May 9, 2025 | finance.yahoo.comInside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambitMay 2, 2025 | cnbc.comZealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?May 1, 2025 | zacks.comZealand Pharma begins mid-stage trial for obesity drug candidate in people with type 2 diabetesApril 24, 2025 | reuters.comZealand Pharma appoints Utpal Singh as Chief Scientific OfficerApril 23, 2025 | contractpharma.comCZealand Pharma appoints Utpal Singh as CSOApril 23, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCLIGF, ZLDPF, HCHDF, ABGLF, and FXCNY Company DescriptionsAcacia Mining OTCMKTS:ABGLF$3.09 0.00 (0.00%) As of 05/12/2021Acacia Mining plc, together with its subsidiaries, mines, processes, and sells gold in Africa. The company has three gold mines in north-west Tanzania, including Bulyanhulu, Buzwagi, and North Mara; and a portfolio of exploration projects at various stages of development in Tanzania, Kenya, Burkina Faso, and Mali. It also produces co-products, such as copper and silver. The company was formerly known as African Barrick Gold plc and changed its name to Acacia Mining plc in November 2014. The company was incorporated in 2010 and is headquartered in London, the United Kingdom. Acacia Mining plc is a subsidiary of Barrick Gold Corporation.Clinigen Group OTCMKTS:CLIGF$8.02 0.00 (0.00%) As of 03/24/2023Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.FIH Mobile OTCMKTS:FXCNY$19.50 0.00 (0.00%) As of 09/17/2025FIH Mobile Limited, an investment holding company, provides integrated manufacturing services for the handset industry worldwide. The company designs, manufactures, and trades in handsets, as well as offers repair services. It is also involved in the research and development activity; manufacture and sale of electronic products; and import and export activities. The company was formerly known as Foxconn International Holdings Limited and changed its name to FIH Mobile Limited in May 2013. FIH Mobile Limited was incorporated in 2000 and is headquartered in New Taipei City, Taiwan. FIH Mobile Limited is a subsidiary of Foxconn (Far East) Limited.Hochschild Mining OTCMKTS:HCHDF$4.13 -0.18 (-4.18%) As of 09/18/2025 03:35 PM EasternHochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. The company holds 100% interests in the Inmaculada gold/silver underground operation and Pallancata silver/gold property, which are located in the Department of Ayacucho in southern Peru. It also holds a 51% interest in the San Jose silver/gold mine located in Argentina. In addition, the company has a portfolio of projects located across Peru, Argentina, Mexico, United States, Canada, Brazil, and Chile. Further, it is involved in the power generation business. Hochschild Mining plc was founded in 1911 and is based in London, the United Kingdom.Zealand Pharma A/S OTCMKTS:ZLDPF$73.31 +4.31 (+6.25%) As of 09/18/2025 02:40 PM EasternZealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Fed Cut Rates: What Now for the S&P 500 and Equity Markets? Eli Lilly’s Oral GLP-1 Breakthrough Could Change Everything Bloom Energy Booms on AI Power Demand and Analyst Upgrades Can Apple’s iPhone 17 and AI Push Its Stock to New Highs? Why Seagate Is Wall Street's New Favorite AI Infrastructure Play New Catalysts Build Positive Pressure on Intel Stock Oracle to Hit $1 Trillion Valuation in 2025: Here’s Why General Mills Is a Generational Opportunity for Income Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
